tirzepatide cvot results Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular

After this period, the pen must be discarded even if unused

GIP affects nutrient absorption timing, insulin secretion, and fat metabolism

Long-TErm chronic intermittent hypobaric hypoxia in rats causes an imbalance in the asymmetric dimethylarginine/nitric oxide pathway and ros activity: a possible synergistic mechanism for altitude pulmonary hypertension

Medicare is statutorily prohibited from covering obesity medications, and Congressional efforts to change that rule have been unsuccessful

2008 Feb;16(2):241-56

According to the FDA prescribing information, nausea occurs in approximately 24-30% of patients taking therapeutic doses of Zepbound